NEW YORK (GenomeWeb) – Pacific Biosciences announced today that it plans to raise gross proceeds of $30 million in a planned public offering of 12.5 million shares of common stock at $2.40 per share.

PacBio will also grant the underwriters a 30-day option to purchase up to almost an additional 1,875,000 shares of its common stock sold in the offering.

Cantor Fitzgerald will act as the sole book-running manager for the offering, which is anticipated to close on Feb. 15th.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.